Durable Long-term Results With Dolutegravir for HIV Suppression

(MedPage Today) -- MONTREAL--A simplified treatment for maintenance of suppression of HIV infection continued to be non-inferior to standard combination antiretroviral therapy (cART), a researcher reported.
After 144 weeks of treatment, 88...